Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 32385 [2015-13924]
Download as PDF
<![CDATA[
32385
Federal Register / Vol. 80, No. 109 / Monday, June 8, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses
per
respondent
Average
burden per
response
(in hrs.)
Total
burden
(in hrs.)
NQDW Intake Questionnaire (complete) ..............
509,742
1
10/60
84,957
NQDW Intake Questionnaire (subset) ..................
26,902
1
1/60
448
NQDW 7-Month Follow-Up Questionnaire ............
659
1
7/60
77
Instructions for Submitting NQDW Intake Questionnaire Electronic Data File to CDC.
Instructions for Submitting NQDW 7-Month Follow-up Electronic Data File to CDC.
NQDW Quitline Services Survey ..........................
54
1
4
1
1
1
216
1
54
4
20/60
72
................................................................................
....................
....................
....................
85,771
Type of respondents
Form name
Quitline callers who contact the
quitline for help themselves.
Caller who contacts the quitline on
behalf of someone else.
Quitline caller who received a quitline
service from the Asian Smokers’
quitline.
Tobacco Control Manager or Their
Designee.
Total ............................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–13849 Filed 6–5–15; 8:45 am]
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2015–13924 Filed 6–5–15; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA), CK15–004, Epicenters for the
Prevention of Healthcare Associated
Infections (HAIs)—Cycle II.
Time and Date: 10:00 a.m.–4:00 p.m., EDT,
July 9, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Epicenters for the Prevention of
Healthcare Associated Infections (HAIs)—
Cycle II’’, FOA CK15–004.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30329–4027,
Telephone: (404) 718–8833.
VerDate Sep<11>2014
17:09 Jun 05, 2015
Jkt 235001
Centers for Disease Control and
Prevention
Office for State, Tribal, Local and
Territorial Support
In accordance with Presidential
Executive Order No. 13175, November
6, 2000, and the Presidential
Memorandum of November 5, 2009, and
September 23, 2004, Consultation and
Coordination with Indian Tribal
Governments, CDC/Agency for Toxic
Substances and Disease Registry
(ATSDR), announces the following
meeting and Tribal Consultation
Session:
Name: Tribal Advisory Committee (TAC)
Meeting and 13th Biannual Tribal
Consultation Session.
Times and Dates: 8:00 a.m.–5:00 p.m.,
August 4, 2015 (TAC Meeting); 8:00 a.m.–
5:00 p.m., August 5, 2015 (13th Biannual
Tribal Consultation Session).
Place: The TAC Meeting and Tribal
Consultation Session will be held at the
Northern Quest, 100 North Hayford Road,
Airway Heights, Washington 99001.
Status: The meetings are being hosted by
CDC/ATSDR in-person only and are open to
the public. Attendees must pre-register for
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
the event by Friday, July 3, 2015, at the
following link: https://www.cdc.gov/tribal/
meetings.html.
Purpose: The purpose of these recurring
meetings is to advance CDC/ATSDR support
for and collaboration with tribes, and to
improve the health of tribes through,
including but not limited to, assisting in
eliminating the health disparities faced by
Indian tribes, ensuring that access to critical
health and human services and public health
services is maximized to advance or enhance
the social, physical, and economic status of
American Indian/Alaska Native (AI/AN)
people; and promoting health equity for all
AI/AN people and communities. To advance
these goals, CDC/ATSDR conducts
government-to-government consultations
with elected tribal officials or their
authorized representatives. Consultation is
an enhanced form of communication that
emphasizes trust, respect, and shared
responsibility. It is an open and free
exchange of information and opinion among
parties that leads to mutual understanding
and comprehension.
Matters for Discussion: The TAC and CDC
leaders will discuss the following public
health topics: Chronic disease prevention
and health promotion in Indian Country,
CDC’s budget, and CDC’s communication and
engagement with tribes; however, discussion
is not limited to these topics.
During the 13th Biannual Tribal
Consultation Session, tribes and CDC leaders
will engage in a listening session with CDC’s
director and have roundtable discussions
with CDC senior leaders. Tribes will also
have an opportunity to present testimony on
tribal health issues.
Tribal leaders are encouraged to submit
written testimony by July 17, 2015, by mail
to Annabelle Allison, Deputy Associate
Director, Tribal Support Unit, Office for
State, Tribal, Local and Territorial Support
(OSTLTS), Centers for Disease Control and
Prevention, 4770 Buford Highway NE., MS
E–70, Atlanta, Georgia 30341, or by email to
TribalSupport@cdc.gov.
Depending on the time available, it might
be necessary to limit each presenter’s time.
The agenda is subject to change as
priorities dictate.
E:\FR\FM\08JNN1.SGM
08JNN1
]]>Agencies
[Federal Register Volume 80, Number 109 (Monday, June 8, 2015)]
[Notices]
[Page 32385]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-13924]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcement (FOA),
CK15-004, Epicenters for the Prevention of Healthcare Associated
Infections (HAIs)--Cycle II.
Time and Date: 10:00 a.m.-4:00 p.m., EDT, July 9, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Epicenters for the Prevention of Healthcare Associated
Infections (HAIs)--Cycle II'', FOA CK15-004.
Contact Person for More Information: Gregory Anderson, M.S.,
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30329-4027, Telephone: (404) 718-
8833.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-13924 Filed 6-5-15; 8:45 am]
BILLING CODE 4163-18-P
